The relationship between insufficiency and clarity Clear or unclear?

Size: px
Start display at page:

Download "The relationship between insufficiency and clarity Clear or unclear?"

Transcription

1 The relationship between insufficiency and clarity Clear or unclear? Christof Keussen Legal Sources in EP and DE Art. 83 EPC: The European patent application shall disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art. Art. 84 EPC: The claims shall define the matter for which protection is sought. They shall be clear and concise and be supported by the description. Sec. 34(3) German Patent Act: An application shall contain: 3. one or more claims defining the subject for which protection is sought; 2 1

2 The EP approach: Different types of insufficient disclosure Type 1: Impossibility of carrying out the invention (classical lack of sufficiency) Type 2: At least one way of carrying out the invention is disclosed, but no concept fit for generalization over the entire claim width (T409/90; T 435/91) A third type increasingly appeared over the last years: Type 3: Ambiguity of the patent claim Insufficiency due to ill-defined claim limits T 464/ the skilled person is faced with a situation in which, at least for some samples, he is not be able to determine whether these samples are in accordance with the claimed invention or not. Therefore, the invention cannot be reproduced over the whole area claimed. 3.5 It must thus be concluded that the patent in suit does not disclose the invention in accordance with claim 1 of the auxiliary request in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art (Article 83 EPC)

3 T 805/93 Insufficiency due to ill-defined claim limits 4. results in uncertainty as to the exact limits of the scope of Claim 1. Therefore, the viscosity cannot be considered to be clearly indicated and the matter for which protection is sought cannot be deemed defined, so that Claim 1 does not comply with Article 84 EPC. 5. For the same reason, the skilled person would be left in considerable doubt as to which compounds to select when choosing the reactive components in order to obtain the reaction product falling within the terms of the claimed adhesive. Therefore, the disclosure of the application in suit does not enable him to carry out the claimed subject-matter on a general basis, so that the requirements of Article 83 EPC are also not met Inside or Outside the Claim Test The cited decisions led to the development of the Inside or Outside the Claim Test. Thereafter the skilled person has to be able to determine whether each conceivable embodiment is within or outside the scope of the claim. Otherwise there is not just lack of clarity but also lack of sufficient disclosure. Considerable risk for patent claims defining the invention using measurable quantities (parameters). Parameters in patent claims are often important in order to obtain an appropriate scope of protection

4 T 1405/05 No enablement in a gray zone Claim was directed to a range for a length of a fiber The term length of a fiber was not defined, an interpretation in two different ways was possible For one of these interpretations neither fibers nor their fabrication were disclosed Patent claims in the broadest reasonable interpretation did include a variant that could not be carried out Enabling disclosure under Art. 83 EPC denied Gray zone penetrates the entire scope of the claim T 541/09 Claimed MW (molecular weight) range: Measurement inaccuracy of MW roughly 20% due to insufficiently disclosed measurement method Measurement inaccuracy of the lower limit approx , upper limit approx Determination of MW not reliable in the entire scope of the claim Compliance with the claimed MW range is described as essential in order to solve the technical problem in the patent Result: No enabling disclosure

5 Gray zone is overlapping with the state of the art T 1404/08 The definition of a claim limit is unclear, which leads to a problem under Art. 84 EPC, no ground for opposition Several possible interpretations of the ill-defined feature all applicable If a state of the art exists, that discloses at least one of the possible claim interpretations, this results in a lack of novelty Application of this principle to the evaluation of inventive step is possible, smallest possible gap between the state of the art and a possible claim interpretation is critical for the determination of inventive step No technical effect in the gray zone T 939/92: Inventive step is acknowledged only if the relevant technical effect is present over the whole area claimed Application of this principle to unclear claims: All possible interpretations of the claim are applicable For each possible interpretation of the claim there must be a technical effect that solves the objective technical problem If for at least one of the possible claim interpretations no technical effect can be shown, no inventive step will be acknowledged

6 Summary Ambiguity in the claim will lead to insufficiency if: The gray zone penetrates the entire scope of the claims No enablement in the gray zone Ambiguity in the claim will lead to lack of novelty/inventive step if: The gray zone overlaps with prior art (or comes close) No technical effect in the gray zone The DE approach to clarity not entirely clear Clarity in infringement proceedings BGH X ZR 95/05 Straßenbaumaschine Infringement claim must not be rejected due to lack of patent claim clarity Clarity in revocation proceedings BGH X ZR 72/08 kosmetisches Sonnenschutzmittel III Lack of clarity no ground for revocation BGH - Xa ZR 54/06 Proxyserversystem Claim amendments of European patents in national revocation proceedings must be compliant with Art. 84 EPC

7 The DE approach to clarity not entirely clear Clarity in examination proceedings BPatG 21W (pat) 13/10 of 22 May 2014 Claims have to define the claimed subject matter in a clear and unambiguous manner (Sec. 34(3) No 3 Patent Act) BPatG 11W (pat) 32/13 of 15 December 2014 Sec. 34(3) No 3 Patent Act is no legal basis for rejecting unclear claims in examination, no provision similar to Art. 84 EPC in the German Patent Act BGH X ZB 8/12 - Dipeptidyl-Peptidase-Inhibitoren Unclarity no ground for revocation, avoidable unclarities must be addressed in examination proceedings Thank you Questions? keussen@glawe.de

8 Crystal clear? Clarity Questions in Prosecution/Opposition Proceedings The views expressed in the presentation are the personal views of the author and are not necessarily shared by any other members of the boards of appeal. The authentic texts of the decisions of the boards and the EPC provisions cited are accessible under Marco Alvazzi Delfrate Technically qualified member, Board February 2015 Substantive aspects Article 84 EPC - Claims The claims shall define the matter for which protection is sought. They shall be clear and concise and be supported by the description. But what is the definition of clear? 2 1

9 Substantive aspects Why there is no clarity test? T 68/85 ( ): synergistic agent for selective weed control. Examining Division: the ratio range of the active ingredients was to be specified. Board: feature must be defined - in the objectively most precise form - without unjustifiably limiting the scope of the invention or unacceptably restricting protection. 3 Substantive aspects The term substantially T 971/10 ( ): a gas-liquid contacting tray which comprises a tray plate with substantially circular circumference... T 637/01 ( ): a vehicle with inductive pick-up means capable of deriving power from a magnetic field and decoupling means to substantially completely disengage the inductive pick-up means from the magnetic field. Examining Division: substantially rendered the claim unclear. Examining Division: substantially rendered the claim unclear. Board: lack of clarity. Board: no lack of clarity! 4 2

10 Substantive aspects The term substantially T 971/10 : Meaning of technical terms in claims neither absolute nor theoretical but what is generally accepted in the technical field. In the field of gas-liquid contacting apparatuses a circular shape never means perfectly circular. Substantially in combination with circular deviations from the circular shape larger than the usual tolerances. No explanation of what the deviations might be impossible to determine the extent of protection. 5 Substantive aspects The term substantially T 637/01: The person skilled in the art understands that to substantially completely disengage does not imply 100% disengagement but prevents resonant current from flowing. In the context of the invention, to substantially completely disengage the inductive pick-up means do therefore, in combination with the other features sufficiently clearly define the matter for which protection is sought. 6 3

11 Substantive aspects Description to be taken into account? T 500/01 ( ): A patent is a legal document may be its own dictionary and determine how to interpret a specific word. Not necessary if the patent does not depart from the normal meaning of the word in the technical field. If different meaning is intended, the description may give this word a special, overriding meaning by explicit definition. 7 Substantive aspects Description to be taken into account? T 1271/05 ( ): Distinction between various terms in the description: no impact on the interpretation of the claim if the distinction is not clear from the wording of the claim alone. Exception to this principle: may exist if the description provides unambiguous definitions of certain terms and makes clear that the definitions apply throughout the complete application. 8 4

12 Substantive aspects How is clarity examined elsewhere? US Supreme Court in NAUTILUS, INC. v. BIOSIG INSTRUMENTS, INC. (2 June 2014). Federal Circuit: a patent satisfies the definiteness requirement if the claim is amenable to construction and not insolubly ambiguous. Supreme Court: A patent is invalid for indefiniteness if its claims, read in light of the patent s specification and prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention. 9 Substantive procedural aspects 10 5

13 Procedural aspects Examination phase Article 84 is comprised in Part III- Chapter I of the EPC Filing and requirements of the European patent application. Clarity always to be examined for all claims. 11 Procedural aspects The patent as granted Clarity not among the grounds of opposition in Article 100 EPC. No opposition based on lack of clarity. Clarity plays no role in filing an opposition? 12 6

14 Procedural aspects The patent as granted T 18/08 ( ): catheter with solution of a therapeutic agent in a concentration of at least 75% of the limit solubility of the therapeutic agent in the solvent. Board: to carry out the invention measurement of the relative concentration of therapeutic agent in the solution. Limit solubility not a common term known to the person skilled in the art and not defined in the description. Patent revoked on the basis of Article 100(b). 13 Procedural aspects The patent as granted No hidden Article 84 objection! T 608/07 ( ): not enough if ambiguity effect only at edges of the claims but does not permeate whole claim. T 2403/11 ( ): four-step approach (problem solved; relevance of parameter; ambiguity of parameter; link ambiguity-relevance for problem solution). 14 7

15 Procedural aspects Amended patent Article 101 (3) EPC: if the patent is amended the patent and the invention to which it relates must meet the requirements of the EPC. Examination completely re-opened if patent amended? 15 Procedural aspects Amended patent G 9/91 ( ): In case of amendments of the claims or other parts of a patent in the course of opposition or appeal proceedings, such amendments are to be fully examined as to their compatibility with the requirements of the EPC. T 301/87 ( ): Absurd if making a minor amendment could enable objections outside Article 100 EPC with no connection with the amendment itself. No objections based upon Article 84 EPC, if such objections do not arise out of the amendments made. 16 8

16 Procedural aspects Amended patent Objection arise out of amendments? Independent claim amended by inserting feature(s) from the description Clarity to be examined. Independent claim amended by inserting feature(s) from the dependent claims Clarity to be examined? 17 Procedural aspects Combination of granted claims T 301/87 ( ), T 367/96 ( ), T 381/02 ( ), T 1855/07 ( ),...: Substantial amendments to be assessed for their compliance with the EPC, but in principle no examination of clarity where a dependent claim as granted is inserted literally into the claim under scrutiny. Clarity not a ground of opposition and the dependent claims already present in granted patent. 18 9

17 Procedural aspects Combination of granted claims T 472/88 ( ), T681/00 ( ): amendment brings into notice an ambiguity that may have existed all along. T 1440/08 ( ): amendment gave rise to a contradiction in the amended claim. T 1459/05 ( ): not all the dependent claims sistematically examined. Board empowered to examine clarity in that case, otherwise examination of novelty and inventive step would be hampered. All exceptions not questioning the principle that generally clarity of combination of granted claims should not be examined. 19 Procedural aspects Combination of granted claims T 459/09 ( ): Clarity of an amended independent claim should, in principle, be examined, even if amendment consists in a mere literal combination of claims of the patent as granted. An amendment consisting of the incorporation of a technically meaningful feature in an independent claim is of a substantial nature irrespective of the kind of amendment performed. T 409/10 ( ): T459/09 is established jurisprudence of the Boards of Appeal

18 Procedural aspects Combination of granted claims T 373/12 ( ): Claim 1 as granted: a prosthetic medical device with a liner comprising a layer of protective and lubricious coating. Claim 1 of auxiliary request 1: combination of granted claims 1 and 3. Dependent claim 3 as granted: liner coated over substantially all of its surface area. Auxiliary request 1 objected for lack of clarity or request of referral to Enlarged Board of Appeal. 21 Procedural aspects Referral G3/14 (T373/12) Combination of granted independent claim with (features from) granted dependent claims 1. Clarity always to be examined? 22 11

19 Procedural aspects Referral G3/14 (T373/12) Combination of granted independent claim with (features from) granted dependent claims 1. Clarity always to be examined? 2. All the features or only inserted features? 23 Procedural aspects Referral G3/14 (T373/12) Combination of granted independent claim with (features from) granted dependent claims 1. Clarity always to be examined? 2. All the features or only inserted features? 3. Never to be examined? 24 12

20 Procedural aspects Referral G3/14 (T373/12) Combination of granted independent claim with (features from) granted dependent claims 1. Clarity always to be examined? 2. All the features or only inserted features? 3. Never to be examined? 4. Under which conditions? 25 Thank you very much for your attention! 26 13

21 Clarity and Sufficiency a UK perspective Iain Purvis QC Legislative Provisions in the UK Insufficiency objection defined by s14(3) of 1977 Patents Act in terms which mirror Article 83 EPC clear enough and complete enough for the invention to be performed by a person skilled in the art Lack of clarity objection defined by s14(5) in terms which mirror Article 84. In particular s14(5)(b) requirement that the claims be clear and concise Section 72 sets out grounds on which Patent may be revoked, mirroring Article 138. So s72(c) allows revocation for insufficiency. All these provisions to be construed as near as practicable to have the same effect as the corresponding provisions of the EPC s130(7). 1

22 Old law in UK prior to 1978 S32(1)(i) of Patents Act 1949 allowed patent to be revoked for ambiguity First case under 1977 Act Genentech s Patent [1989] RPC 147 and 553 First instance Judge held that ambiguity still an objection to validity under inherent power of the Court. Court of Appeal disagreed. No power to revoke on grounds not expressly conferred by statute. So no objection of ambiguity post grant? This was widely believed. 2

23 See Milliken v Walk Off Mats [1996] FSR 292 and Scanvaegt v Pelcombe [1998] FSR 786 where it was said that a truly ambiguous claim was not invalid but simply could not be infringed! The law changed after the House of Lords decision in Kirin Amgen v Hoechst Marion Roussel [2004] UKHL 46 Claim 19 was to repo products having a higher molecular weight by SDS PAGE from erythropoietin isolated from urinary sources. 3

24 Problem: not all uepos had the same molecular weight, irrespective of source and method of isolation. So the scope of the claim was inherently unclear: Simply to use the first uepo which came to hand would turn the claim into a lottery. On the other hand, it would be burdensome to have to work one s way through several specimens of uepo and even then the result would be inconclusive because non constant that some untried specimen did not have a different molecular weight. All the skilled man can do is try to guess which uepo the patentee had in mind and if the specification does not tell him, then it is insufficient Adopted in later cases: SmithKline Beecham v Apotex Europe [2004] EWCA Civ 1568 The meaning of the words solvate and anhydrate are truly ambiguous One just does not know what the patentee meant at all and thus [the claims are] insufficient on the principles laid down by Lord Hoffmann in Kirin Amgen The Courts draw the distinction between: (a) Words in a claim which simply have a fuzzy boundary this can be resolved by the Court so no ambiguity and no insufficiency; and (a) Words which one cannot define at all 4

25 In reality, this distinction is easier to state in words than to apply! The vast majority of cases of potential ambiguity are resolved by construction. Ambiguities at the edge of the claim are generally ignored. See Zipher v Markem [2009] FSR 1 at 374: It will normally be necessary for the problem to permeate the whole claim. Dealing With Clarity Objections on Amendment The party applying to amend in revocation proceedings is obliged to comply with s14(5) in the same way as if he was making an application for a patent. See Horne Engineering v Reliance [2000] FSR 90 at 111 However, the Courts will not revisit questions of clarity arising out of matter which was already in the claim prior to amendment. See Chiron (No.5) [1994] FSR 258 5

26 Thus: mere deletion amendments to existing subsidiary claims will not be subject to s14(5) examination, unless: (i) (possibly) fraud or the like on the Patent Office is alleged see Chiron at 266; or (ii) The existence of the subsidiary claim played a part in the construction of the main claim and therefore its deletion would obscure the scope of that main claim, resolving a potential ambiguity see Plastics SA [1970] RPC 22. These decisions were all taken on the basis of the discretion which the Courts had to disallow applications to amend. However, the position is considered not to have changed in the light of the removal of that discretion and/or the 2004 Act. 6

27 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 Clarity and Sufficiency A Dutch perspective Munich, February 27, 2015 Ricardo Dijkstra Vondst Advocaten Jacob Obrechtstraat KN Amsterdam The Netherlands t: f: e: ricardo.dijkstra@vondst-law.com Grounds for invalidity DPA 1910 Section 51(1)(a) Dutch Patent Act 1910 (before 1 December 1987): A patent shall be invalidated insofar as: a. [ ], if a European patent is concerned, the patent should not have been granted according to sections of the European Patent Convention. No reference to section 83 EPC, also not to 138 EPC October 2009, Otto Swens, Vondst Advocaten 1

28 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 Parliamentary history 51 DPA Netherlands Patent Office and only grant a patent for sufficiently disclosed inventions. Therefore, there is no need to introduce insufficient disclosure as invalidity ground in the Dutch Patent Act. Amendment 51 DPA Amendment Act 29 May 1987 (in force 1 December 1987) amended Section 51(1)(a) Dutch Patent Act 1910: A patent shall be invalidated insofar as: a. [ ], if a European patent is concerned, the patent should not have been granted according to sections of the European Patent Convention; b. the patent specification does not contain a description of the invention that [ ] is sufficiently clear and complete to allow a person skilled in the art to perform the invention; October 2009, Otto Swens, Vondst Advocaten 2

29 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 Supreme Court, Navcom / Philips, 2005 Section 57 EPC: An invention shall be considered as susceptible of industrial application if it can be made or used in any kind of industry, including agriculture. Section 83 EPC: The European patent application shall disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art. Does section 83 EPC further elaborate on section 57 EPC and was the amendment of the Dutch Patent Act therefore unnecessary? Supreme Court, Navcom / Philips, 2005 Section 51(1) Dutch Patent Act refers to section EPC and not to section 138 EPC. Section 138 EPC leaves room to the member states to deviate from 138 EPC. The legislator explicitly chose to refer to section EPC. Supreme Court quashed the decision of the Court of Appeal that used the criterion of insufficient disclosure for lack of industrial susceptibility. October 2009, Otto Swens, Vondst Advocaten 3

30 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 Supreme Court, Navcom / Philips, 2005 Dissatisfactory outcome, but legal certainty, legal methodology and legal history should prevail. Other options: use insufficient disclosure in order to interpret the patent for an argument based on lack of inventive step. use insufficient disclosure in order to limit the scope of protection. District Court, Novartis / J&J, 2009 Claim 1 attempts to define the invention by a result (maintain corneal health and wearer comfort) and therefore unclear. Lack of clarity (84 EPC) not a ground for invalidity (EPO Guidelines, C, III-8, par 4.10, now: F, Chapter IV, par. 4.10). J&J did not show insufficiency (83 EPC). Person skilled in the art will recognize the error in the formula used in the description and apply the correct formula. October 2009, Otto Swens, Vondst Advocaten 4

31 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 District Court, Novozymes / DSM, 2010 Novozymes argues that the arguments of DSM regarding insufficiency are in fact clarity objections under section 84 EPC. District Court refers to Guidelines: It should be noted that, although an objection of lack of support is an objection under Art. 84, it can often, as in the above examples, also be considered as an objection of insufficient disclosure of the invention under Art. 83 [ ], the objection being that the disclosure is insufficient to enable the skilled person to carry out the "invention" over the whole of the broad field claimed (although sufficient in respect of a narrow "invention ). District Court, Novozymes / DSM, 2010 The District Court finds that section 83 EPC requires that the patent specification describes the invention sufficiently clear and complete that the invention can be performed without undue burden throughout the entire area of the claim. The patent specification and common general knowledge has to enable the person skilled in the art to reproduce at least a substantial part of the embodiments of the invention. District Court does not allow free beer claims: Novozymes tries to protect something that everyone would want (free beer), without clearly disclosing how the person skilled in the art could reach such desirable results. October 2009, Otto Swens, Vondst Advocaten 5

32 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 District Court, Bayer / Abbott, 2010 An invention may be described in functional terms, but this should be omitted if it is not necessary and not in accordance with the contribution to the state of the art. The interest of third parties is a viewpoint to be taken into account. In all cases, the sufficiency requirement entails that the invention can be performed without undue burden throughout the entire area of the claim. The District Court notes that this is not the case if the technology to perform the invention throughout the entire area of the claim is not available. Insufficiency: Bayer claims more than it technically made available. District Court, PPG / Rhodia, 2013 The desired product characteristics in the method claim dependent on a lot of parameters in the fabrication process and small changes can lead to great changes in product characteristics. High demands on the description of the method. Claimed range of the parameters in claim 1, the description and the examples too broad. 5 out of 6 experiments did not result in the claimed products with the advantageous characteristics. Claim 1 invalid based on insufficient disclosure. October 2009, Otto Swens, Vondst Advocaten 6

33 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 District Court, Permavoid / HTW, 2015 HTW argues that the invention is insufficiently disclosed, because it is unclear for the person skilled in the art what a feature ( direct ) in the claim means. Lack of clarity as such does not necessarily lead to insufficiency. HTW did not show that a person skilled in the art could not perform the claimed invention. Lack of clarity (section 84 EPC) not a ground for invalidity. A matter of interpretation Supreme Court, Navcom / Philips, 2005 (find other ways) Use lack of clarity for: Subject matter not patentable (52 57 EPC) Insufficient disclosure Added subject matter Extension of protection Scope of protection October 2009, Otto Swens, Vondst Advocaten 7

34 The impact of the EU Enforcement Directive on Dutch IP litigation London, October 5, 2009 A matter of interpretation Lack of clarity for the average person skilled in the art works in principle to the detriment of the patentee. (Supreme Court, Ciba Geigy / Ote Optics, 1995; Supreme Court, Lely / Delaval, 2007; Supreme Court, Medinol / Abbott, 2014) There are no facts, only interpretations (Friedrich Nietzsche) Any questions? Ricardo Dijkstra Vondst Advocaten Jacob Obrechtstraat KN Amsterdam The Netherlands t: f: e: ricardo.dijkstra@vondst-law.com October 2009, Otto Swens, Vondst Advocaten 8

Allowability of disclaimers before the European Patent Office

Allowability of disclaimers before the European Patent Office PATENTS Allowability of disclaimers before the European Patent Office EPO DISCLAIMER PRACTICE The Boards of Appeal have permitted for a long time the introduction into the claims during examination of

More information

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems - comparison and interaction between the EPO appeal system and the national judicial systems 22 nd Annual Fordham IP Law & Policy Conference 24 April 2014, NYC by Dr. Klaus Grabinski Federal Court of Justice,

More information

News and analysis on IP law, regulation and policy from around the world. For the latest updates, visit

News and analysis on IP law, regulation and policy from around the world. For the latest updates, visit WORLD INTELLECTUAL PROPERTY REPORT >>> News and analysis on IP law, regulation and policy from around the world. For the latest updates, visit www.bna.com International Information for International Business

More information

Keywords: patent, construction, infringement, Amgen, equivalents, protocol

Keywords: patent, construction, infringement, Amgen, equivalents, protocol William Cook is a specialist intellectual property solicitor, and advises clients on all aspects of IP protection, licensing and enforcement, with particular focus on patent matters. In recent years, he

More information

Recent EPO Decisions: Part 1

Recent EPO Decisions: Part 1 Oliver Rutt RSC Law Group IP Case Law Seminar 9 November 2017 Decisions G1/15 Partial Priority T260/14 Partial Priority T1543/12 Sufficiency T2602/12 Admissibility T2502/13 Article 123(2) EPC / Disclaimers

More information

Claim interpretation by the Boards of Appeal of the EPO

Claim interpretation by the Boards of Appeal of the EPO Claim interpretation by the Boards of Appeal of the EPO UNION Round Table: How to Cope with Patent Scope - Literal Interpretation of Claims throughout Europe Munich, 26 February 2010 Dr. Rainer Moufang

More information

should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art

should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art Added subject-matter Added subject-matter in Europe The European patent application should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled

More information

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law Elisabetta Papa Società Italiana Brevetti S.p.A. Functional claiming is allowed under the EPC and related case-law, with a few disclosure-specific

More information

The EPO Enlarged Board of Appeal decides on dosage regimens (G2/08) and treatment by surgery (G1/07)

The EPO Enlarged Board of Appeal decides on dosage regimens (G2/08) and treatment by surgery (G1/07) The EPO Enlarged Board of Appeal decides on dosage regimens (G2/08) and treatment by surgery (G1/07) Dr. Benjamin Quest and Dr. Franz-Josef. Zimmer The two recent decisions of the Enlarged Board of Appeal

More information

IP Report Patent Law. The right of priorities: Recent developments in EPO case law Reported by Dr. Rudolf Teschemacher

IP Report Patent Law. The right of priorities: Recent developments in EPO case law Reported by Dr. Rudolf Teschemacher The right of priorities: Recent developments in EPO case law Reported by Dr. Rudolf Teschemacher Recent decisions passed by three different instances of the EPO have significant effects on the patentability

More information

The Same Invention or Not the Same Invention? Thorsten Bausch

The Same Invention or Not the Same Invention? Thorsten Bausch The Same Invention or Not the Same Invention? Thorsten Bausch FICPI World Congress Munich 2010 CONTENTS The Same Invention or Not the Same Invention? Practical Problems The standard of sameness the skilled

More information

Abstract. Keywords. Kotaro Kageyama. Kageyama International Law & Patent Firm, Tokyo, Japan

Abstract. Keywords. Kotaro Kageyama. Kageyama International Law & Patent Firm, Tokyo, Japan Beijing Law Review, 2014, 5, 114-129 Published Online June 2014 in SciRes. http://www.scirp.org/journal/blr http://dx.doi.org/10.4236/blr.2014.52011 Necessity, Criteria (Requirements or Limits) and Acknowledgement

More information

Dawn of an English Doctrine of Equivalents: immaterial variants infringe

Dawn of an English Doctrine of Equivalents: immaterial variants infringe Dawn of an English Doctrine of Equivalents: immaterial variants infringe November 2017 The Supreme Court reinvents patent infringement The Supreme Court s landmark judgment in Actavis v Eli Lilly is a

More information

HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION

HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION HOW HIGH HAS THE BAR BEEN RAISED? THE AUSTRALIAN PATENT OFFICE ISSUES ITS FIRST OPPOSITION DECISION ON A POST RAISING THE BAR PATENT APPLICATION 21 January 2016 Australia, Brisbane, Melbourne, Perth, Sydney

More information

Drafting international applications with Europe in mind. Dr. Matthew Barton, UK and European patent attorney, Forresters

Drafting international applications with Europe in mind. Dr. Matthew Barton, UK and European patent attorney, Forresters Drafting international applications with Europe in mind Dr. Matthew Barton, UK and European patent attorney, Forresters Introduction The European patent office (EPO) perhaps has a reputation for having

More information

2016 Study Question (Patents)

2016 Study Question (Patents) 2016 Study Question (Patents) Submission date: 9th May 2016 Sarah MATHESON, Reporter General John OSHA and Anne Marie VERSCHUUR, Deputy Reporters General Yusuke INUI, Ari LAAKKONEN and Ralph NACK, Assistants

More information

Lessons learnt 6 February 2015

Lessons learnt 6 February 2015 Lessons learnt from patent case law in Europe in 2013 and 2014 Véron & Associés Seminar Paris Maison de la Recherche 6 February 2015 Isabelle Romet Paris Lyon 1. Main teachings of 2013-2014 (1/2) 1. Possible

More information

Patent Claims. Formal requirements and allowable amendments. 2005Jaroslav Potuznik

Patent Claims. Formal requirements and allowable amendments. 2005Jaroslav Potuznik Patent Claims Formal requirements and allowable amendments 2005Jaroslav Potuznik Examination as to formal requirements (compliance with Articles 42 to 52) is performed according Art. 54, upon the filing.

More information

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT)

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT) Litigators Asscociation EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT) ACTAVIS V LILLY MILAN, 14 MAY 2018 EUROPEAN PATENT LITIGATORS ASSOCIATION Actavis UK Limited and others (Appellants) v Eli Lilly and

More information

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position Dr Peter Meier-Beck Presiding Judge at the Bundesgerichtshof Honorary Professor at the University of Düsseldorf FICPI

More information

Note concerning the Patentability of Computer-Related Inventions

Note concerning the Patentability of Computer-Related Inventions PATENTS Note concerning the Patentability of Computer-Related Inventions INTRODUCTION I.THE MAIN PROVISIONS OF THE EUROPEAN CONVENTION II. APPLICATION OF THESE PROVISIONS AND MAINSTREAM CASELAW OF THE

More information

Partial Priorities and Transfer of Priority Rights. Dr. Joachim Renken

Partial Priorities and Transfer of Priority Rights. Dr. Joachim Renken Partial Priorities and Transfer of Priority Rights Dr. Joachim Renken AN EXAMPLE... 15 C Prio 20 C Granted Claim 10 C 25 C In the priority year, a document is published that dicloses 17 C. Is this document

More information

EPO Decision G 1/15 on Partial Priorities and Toxic Divisionals: Relief and Risks

EPO Decision G 1/15 on Partial Priorities and Toxic Divisionals: Relief and Risks EPO Decision G 1/15 on Partial Priorities and Toxic Divisionals: Relief and Risks In Europe, the claiming of multiple priorities and the concept of partial priority in the context of a single patent claim

More information

IPFocus LIFE SCIENCES 9TH EDITION WHEN IS POST-PUBLISHED EVIDENCE ACCEPTABLE? VALEA

IPFocus LIFE SCIENCES 9TH EDITION WHEN IS POST-PUBLISHED EVIDENCE ACCEPTABLE? VALEA IPFocus LIFE SCIENCES 9TH EDITION WHEN IS POST-PUBLISHED EVIDENCE ACCEPTABLE? VALEA 2011 EPO: INVENTIVE STEP When is post-published evidence acceptable? Ronney Wiklund and Anette Romare of Valea discuss

More information

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO) COMPARATIVE STUDY REPORT ON INVENTIVE STEP (JPO - KIPO - SIPO) CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative criteria

More information

Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis transmutes sodium into potassium but will it provide gold for patentees?

Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis transmutes sodium into potassium but will it provide gold for patentees? WHITEHEAD AND JACKSON : ALCHEMY IN THE UK: THE SUPREME COURT IN ELI LILLY v ACTAVIS TRANSMUTES SODIUM INTO POTASSIUM : VOL 16 ISSUE 3 BSLR 135 Alchemy in the UK: the Supreme Court in Eli Lilly V Actavis

More information

Standing Committee on the Law of Patents

Standing Committee on the Law of Patents E SCP/22/4 ORIGINAL: ENGLISH DATE: MAY 5, 2015 Standing Committee on the Law of Patents Twenty-Second Session Geneva, July 27 to 31, 2015 STUDY ON THE SUFFICIENCY OF DISCLOSURE Document prepared by the

More information

DRAFT. prepared by the International Bureau

DRAFT. prepared by the International Bureau December 2, 2004 DRAFT ENLARGED CONCEPT OF NOVELTY: INITIAL STUDY CONCERNING NOVELTY AND THE PRIOR ART EFFECT OF CERTAIN APPLICATIONS UNDER DRAFT ARTICLE 8(2) OF THE SPLT prepared by the International

More information

Patent litigation. Block 1. Module Priority. Essentials: Priority. Introduction

Patent litigation. Block 1. Module Priority. Essentials: Priority. Introduction Patent litigation. Block 1. Module Priority Introduction Due to the globalisation of markets and the increase of inter-state trade, by the end of the nineteenth century there was a growing need for internationally

More information

Eli Lilly v Actavis. Mark Engelman Head of Intellectual Property

Eli Lilly v Actavis. Mark Engelman Head of Intellectual Property Eli Lilly v Actavis Mark Engelman Head of Intellectual Property mark.engelman@hardwicke.co.uk Topics 1. Literalism 2. Ely Lilly v Actavis The Facts 3. Catnic Components Ltd v Hill & Smith Ltd [1982] RPC

More information

Claim amendments - a case for national proceedings in the life science field?

Claim amendments - a case for national proceedings in the life science field? Claim amendments - a case for national proceedings in the life science field? Dr. Leo Polz German Patent Attorney European Patent Attorney Partner Dott. Marco Benedetto Italian Patent Attorney European

More information

Disclaimers at the EPO

Disclaimers at the EPO Introduction Enlarged Board of Appeal ("EBA") decision G 2/10 (August 2011) sought to clarify a previously existing divergence of interpretation as to the general question of when a disclaimer may be validly

More information

Suzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup.

Suzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup. Differences between US and EU Patent Laws that Could Cost You and Your Startup Suzannah K. Sundby United States canady + lortz LLP Europe David Read UC Center for Accelerated Innovation October 26, 2015

More information

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal 1. Small molecules 1.1 Product and process claims Classic drug development works with small, chemically manufactured

More information

Netherlands. Report Q 175

Netherlands. Report Q 175 1 Netherlands Report Q 175 in the name of the Dutch Group K.A.J. Bisschop, R.E. Ebbink (chair), A.E. Heezius, M.H.J. van den Horst, A. Killan, A.A.G. Land, C.S.M. Morel The role of equivalents and prosecution

More information

Intellectual Property and crystalline forms. How to get a European Patent on crystalline forms?

Intellectual Property and crystalline forms. How to get a European Patent on crystalline forms? Intellectual Property and crystalline forms How to get a European Patent on crystalline forms? Ambrogio Usuelli Chief-Examiner European Patent Office, Munich, Germany Bologna, 19th January 2012 Sponsor:

More information

DETAILED TABLE OF CONTENTS

DETAILED TABLE OF CONTENTS DETAILED TABLE OF CONTENTS Preface... v v About the Authors... xiii vii Summary Table of Contents... xv ix Chapter 1. European Patent Law as International Law... 1 I. European Patent Law Arises From Multiple

More information

The Netherlands Pays Bas Niederlande. Report Q189. in the name of the Dutch Group

The Netherlands Pays Bas Niederlande. Report Q189. in the name of the Dutch Group The Netherlands Pays Bas Niederlande Report Q189 in the name of the Dutch Group Amendment of patent claims after grant (in court and administrative proceedings, including re examination proceedings requested

More information

Double Patenting at the EPO

Double Patenting at the EPO Double Patenting at the EPO I. Summary Recent case law confirms that patents granted on parent and divisional applications cannot contain claims of identical scope, and potentially restricts the ability

More information

An introduction to European intellectual property rights

An introduction to European intellectual property rights An introduction to European intellectual property rights Scott Parker Adrian Smith Simmons & Simmons LLP 1. Patents 1.1 Patentable inventions The requirements for patentable inventions are set out in Article

More information

ARE EXPRESSED SEQUENCE TAGS PATENTABLE UNDER THE EUROPEAN PATENT CONVENTION? A PRACTITIONER'S VIEW

ARE EXPRESSED SEQUENCE TAGS PATENTABLE UNDER THE EUROPEAN PATENT CONVENTION? A PRACTITIONER'S VIEW ARE EXPRESSED SEQUENCE TAGS PATENTABLE UNDER THE EUROPEAN PATENT CONVENTION? A PRACTITIONER'S VIEW Dr. Franz Zimmer Partner of Grünecker, Kinkeldey, Stockmair & Schwanhäusser The Human Genome Project (HGP)

More information

CA/PL 7/99 Orig.: German Munich, SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) President of the European Patent Office

CA/PL 7/99 Orig.: German Munich, SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) President of the European Patent Office CA/PL 7/99 Orig.: German Munich, 2.3.1999 SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) DRAWN UP BY: ADDRESSEES: President of the European Patent Office Committee on Patent Law (for opinion) SUMMARY

More information

Title: The patentability criterion of inventive step / non-obviousness

Title: The patentability criterion of inventive step / non-obviousness Question Q217 National Group: China Title: The patentability criterion of inventive step / non-obviousness Contributors: [Heather Lin, Gavin Jia, Shengguang Zhong, Richard Wang, Jonathan Miao, Wilson Zhang,

More information

Current Patent Litigation Trends: UK and Germany

Current Patent Litigation Trends: UK and Germany Volume 26, Number 7 July 2012 Reproduced with permission from World Intellectual Property Report, 26 WIPR 40, 07/01/2012. Copyright 2012 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com

More information

Europe Divided Update on National Case Law in Europe

Europe Divided Update on National Case Law in Europe Europe Divided Update on National Case Law in Europe Leythem Wall 29 November 2011 European Patents 38 EPC Member States as of 1 January 2011 Centralized prosecution Bundle of national patents Articles

More information

POST-GRANT AMENDMENT JOHN RICHARDS

POST-GRANT AMENDMENT JOHN RICHARDS 23 rd Annual Fordham Intellectual Property Law & Policy Conference Cambridge, April 8-9, 2015 POST-GRANT AMENDMENT JOHN RICHARDS The Problem There is a real life problem in that when filing a patent application

More information

Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art "Kastner"

Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art Kastner 28 IIC 114 (1997) UNITED KINGDOM Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art. 69 - "Kastner" 1. A patent specification must be construed as a

More information

COMMENTARY. Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities. Summary of the Enlarged Board of Appeal s Decision

COMMENTARY. Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities. Summary of the Enlarged Board of Appeal s Decision March 2017 COMMENTARY Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities Beginning in 2009, the Boards of Appeal of the European Patent Office ( EPO ) issued a series of decisions

More information

AIPPI REPORT OF THE NETHERLANDS GROUP ON 2016 STUDY QUESTION (PA- TENTS) ADDED MATTER: THE STANDARD FOR DETERMINING ADEQUATE SUPPORT FOR AMENDMENTS

AIPPI REPORT OF THE NETHERLANDS GROUP ON 2016 STUDY QUESTION (PA- TENTS) ADDED MATTER: THE STANDARD FOR DETERMINING ADEQUATE SUPPORT FOR AMENDMENTS AIPPI REPORT OF THE NETHERLANDS GROUP ON 2016 STUDY QUESTION (PA- TENTS) ADDED MATTER: THE STANDARD FOR DETERMINING ADEQUATE SUPPORT FOR AMENDMENTS Members of the working group: Jeroen Boelens; Sophie

More information

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 - COMPARATIVE STUDY REPORT ON TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 - CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative

More information

Questionnaire May 2003 Q Scope of Patent Protection. Response of the UK Group

Questionnaire May 2003 Q Scope of Patent Protection. Response of the UK Group Questionnaire May 2003 Q 178 - Scope of Patent Protection Response of the UK Group 1.1 Which are, in your view, the fields of technology in particular affected by recent discussions concerning the scope

More information

11th Annual Patent Law Institute

11th Annual Patent Law Institute INTELLECTUAL PROPERTY Course Handbook Series Number G-1316 11th Annual Patent Law Institute Co-Chairs Scott M. Alter Douglas R. Nemec John M. White To order this book, call (800) 260-4PLI or fax us at

More information

AIPPI Study Question - Conflicting patent applications

AIPPI Study Question - Conflicting patent applications Study Question Submission date: April 30, 2018 Sarah MATHESON, Reporter General Jonathan P. OSHA and Anne Marie VERSCHUUR, Deputy Reporters General Yusuke INUI, Ari LAAKKONEN and Ralph NACK, Assistants

More information

Draft Rules relating to Unitary Patent Protection revised version of Rules 1 to 11 of SC/16/13

Draft Rules relating to Unitary Patent Protection revised version of Rules 1 to 11 of SC/16/13 SC/22/13 Orig.: en Munich, 22.11.2013 SUBJECT: SUBMITTED BY: ADDRESSEES: Draft Rules relating to Unitary Patent Protection revised version of Rules 1 to 11 of SC/16/13 President of the European Patent

More information

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law Art. 123(2) EPC ADDED MATTER A US Perspective by Enrica Bruno Patent Attorney US Background: New matter Relevant provisions 35 USC 132 or 35 USC 251 If new subject matter is added to the disclosure, whether

More information

It is all crystal clear by definition... (and don t blame us if it isn t)

It is all crystal clear by definition... (and don t blame us if it isn t) It is all crystal clear by definition... (and don t blame us if it isn t) Casual observations on claim interpretation in the European Patent Office Tamás Bokor Member of the Boards of Appeal of the European

More information

APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY

APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY 1. The decisions of two differently constituted High Courts in Kimberly-Clark Australia Pty Ltd v Arico Trading International Pty Ltd (2001) 207 CLR

More information

Patent Claim Construction: Phillips v. AWH (Fed. Cir., July 12, 2005) (en banc) Edward D. Manzo August Patent in Suit

Patent Claim Construction: Phillips v. AWH (Fed. Cir., July 12, 2005) (en banc) Edward D. Manzo August Patent in Suit Patent Claim Construction: Phillips v. AWH (Fed. Cir., July 12, 2005) (en banc) Edward D. Manzo August 2005 Patent in Suit 1 Patent in Suit Claim 1 1. Building modules adapted to fit together for construction

More information

The life of a patent application at the EPO

The life of a patent application at the EPO The life of a patent application at the EPO Yves Verbandt Noordwijk, 31/03/2016 Yves Verbandt Senior expert examiner Applied Physics guided-wave optics optical measurements flow and level measurements

More information

Patent Enforcement UK perspectives

Patent Enforcement UK perspectives Patent Enforcement UK perspectives Options for Patentees and Potential Defendants Ian Kirby Partner FICPI St. Petersburg 6 October 2016 UK: Key Factors 1) Choice of court 2) Types of patent claim 3) Preliminary

More information

ti Litigating Patents Overseas: Country Specific Considerations Germany There is no "European" litigation system.

ti Litigating Patents Overseas: Country Specific Considerations Germany There is no European litigation system. Wolfgang Festl-Wietek of Viering Jentschura & Partner Speaker 11: 1 LSI Law Seminars International ti Litigating Patents Overseas: Country Specific Considerations Germany by Wolfgang Festl-Wietek Viering,

More information

11th Annual Patent Law Institute

11th Annual Patent Law Institute INTELLECTUAL PROPERTY Course Handbook Series Number G-1316 11th Annual Patent Law Institute Co-Chairs Scott M. Alter Douglas R. Nemec John M. White To order this book, call (800) 260-4PLI or fax us at

More information

EUROPEAN PATENT OFFICE Guidelines for Examination Part E - Guidelines on General Procedural Matters Amended in December, 2007

EUROPEAN PATENT OFFICE Guidelines for Examination Part E - Guidelines on General Procedural Matters Amended in December, 2007 EUROPEAN PATENT OFFICE Guidelines for Examination Part E - Guidelines on General Procedural Matters Amended in December, 2007 CONTENTS INTRODUCTION CHAPTER I COMMUNICATIONS AND NOTIFICATIONS 1. Communications

More information

European Patent Convention, Art. 69, Interpretation Protocol; Patent Act 1910, Art. 30(2) (former) - "Contact Lens Liquid"

European Patent Convention, Art. 69, Interpretation Protocol; Patent Act 1910, Art. 30(2) (former) - Contact Lens Liquid 28 IIC 748 (1997) NETHERLANDS European Patent Convention, Art. 69, Interpretation Protocol; Patent Act 1910, Art. 30(2) (former) - "Contact Lens Liquid" 1. In order to determine the scope of protection

More information

Title: The patentability criterion of inventive step / non-obviousness

Title: The patentability criterion of inventive step / non-obviousness Question Q217 National Group: Netherlands Title: The patentability criterion of inventive step / non-obviousness Contributors: Bas Pinckaers (chairman), Moïra Truijens, Willem Hoorneman, Paul van Dongen,

More information

Tools and Pitfalls Recent Decisions from the EPO Boards of Appeal 20 November 2014

Tools and Pitfalls Recent Decisions from the EPO Boards of Appeal 20 November 2014 Tools and Pitfalls Recent Decisions from the EPO Boards of Appeal 20 November 2014 Presented by: Leythem A. Wall Overview Acceleration of Appeal Proceedings Double Patenting Admissibility of Appeals Added

More information

Attention: Ms Chung Ka Yee 29 January Re: Feedback on Proposed Changes to Chapter 8 Of The Examination Guidelines For Patent Applications

Attention: Ms Chung Ka Yee 29 January Re: Feedback on Proposed Changes to Chapter 8 Of The Examination Guidelines For Patent Applications Intellectual Property Office Of Singapore 51 Bras Basah Road #01-01, Manulife Centre Singapore 189554 Attention: Ms Chung Ka Yee 29 January 2016 Dear Ka Yee, Re: Feedback on Proposed Changes to Chapter

More information

Section I New Matter. (June 2010) 1. Relevant Provision

Section I New Matter. (June 2010) 1. Relevant Provision Section I New Matter 1. Relevant Provision Patent Act Article 17bis(3) reads: any amendment of the description, scope of claims or drawings shall be made within the scope of the matters described in the

More information

How patents work An introduction for law students

How patents work An introduction for law students How patents work An introduction for law students 1 Learning goals The learning goals of this lecture are to understand: the different types of intellectual property rights available the role of the patent

More information

ExCo Berlin, Germany

ExCo Berlin, Germany A I P P I ASSOCIATION INTERNATIONALE POUR LA PROTECTION DE LA PROPRIETE INTELLECTUELLE INTERNATIONAL ASSOCIATION FOR THE PROTECTION OF INTELLECTUAL PROPERTY INTERNATIONALE VEREINIGUNG FÜR DEN SCHUTZ DES

More information

Examination Guidelines for Patent Applications. Block I - Tittle, Specification, Claim Chart, Drawings and Abstract

Examination Guidelines for Patent Applications. Block I - Tittle, Specification, Claim Chart, Drawings and Abstract Examination Guidelines for Patent Applications Block I - Tittle, Specification, Claim Chart, Drawings and Abstract This text is an integral part of the Patent Application Examination Guidelines. The Guidelines

More information

QUESTION 89. Harmonization of certain provisions of the legal systems for protecting inventions

QUESTION 89. Harmonization of certain provisions of the legal systems for protecting inventions QUESTION 89 Harmonization of certain provisions of the legal systems for protecting inventions Yearbook 1989/II, pages 324-329 Executive Committee of Amsterdam, June 4-10, 1989 Q89 Question Q89 Harmonisation

More information

Software patenting in a state of flux

Software patenting in a state of flux Software patenting in a state of flux Ewan Nettleton is a senior associate solicitor in the Intellectual Property Department at Bristows. He specialises in Intellectual Property Law with an emphasis on

More information

The use of prosecution history in post-grant patent proceedings

The use of prosecution history in post-grant patent proceedings Question Q229 National Group: Netherlands Title: The use of prosecution history in post-grant patent proceedings Contributors: Reporter within Working Committee: John ALLEN (Chair), Bas Berghuis van Woortman,

More information

SFIR / AIPPI 31 August Amendment of patent claims in France. Partial revocation of a claim by Court (only possibility until January 1, 2009)

SFIR / AIPPI 31 August Amendment of patent claims in France. Partial revocation of a claim by Court (only possibility until January 1, 2009) Amendment of patent claims in France SFIR / AIPPI 31 August 2009 Isabelle Romet Paris Lyon Content 1. 2. Partial revocation of a claim by Court (only possibility until January 1, 2009) Ex-parte limitation

More information

The opposition procedure and limitation and revocation procedures

The opposition procedure and limitation and revocation procedures The opposition procedure and limitation and revocation procedures Closa Daniel Beaucé Gaëtan 26-30/11/2012 Contents Introduction Legal framework Procedure Intervention of the assumed infringer Observations

More information

10 Strategic Drafting of Applications for U.S. Patents by Japanese Companies from an Enforcement Perspective

10 Strategic Drafting of Applications for U.S. Patents by Japanese Companies from an Enforcement Perspective 10 Strategic Drafting of Applications for U.S. Patents by Japanese Companies from an Enforcement Perspective It has become more and more important for Japanese companies to obtain patents in Europe and

More information

JETRO seminar. Recent Rule change and latest developments at the EPO:

JETRO seminar. Recent Rule change and latest developments at the EPO: JETRO seminar Recent Rule change and latest developments at the EPO: Alfred Spigarelli Director Patent procedures management DG1 Business services EPO Düsseldorf 4 November, 2010 Overview RAISING THE BAR

More information

4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA

4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA 4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA Provisions of the Indian patent law were compared with the relevant provisions of the patent laws in U.S., Europe and

More information

Presumption Of Patent Validity In Patent Litigations The New Trends

Presumption Of Patent Validity In Patent Litigations The New Trends Presumption Of Patent Validity In Patent Litigations The New Trends 11 th EGA Legal Affairs Forum March 27, 2015 Kristof Roox, Partner, Crowell & Moring Contents A. Prima facie" validity of patents in

More information

Comparison between Opposition Systems in Europe and Japan

Comparison between Opposition Systems in Europe and Japan Comparison between Opposition Systems in Europe and Japan First published in Patent 2017, Vol. 70, No.5 Authors: Dr. Christian Köster European Patent Attorney Kazuya Sekiguchi Japanese and European Patent

More information

WSPLA (Wash. State Patent Law Assoc.) Lunch Seminar

WSPLA (Wash. State Patent Law Assoc.) Lunch Seminar WSPLA (Wash. State Patent Law Assoc.) Lunch Seminar Date: March 15, 2017 12:00-1:30~2:00 Place: Seattle, WA (Washington Athletic Club 1325 6 th Ave. Seattle 98101) 1 Dos and Don ts of US Inbound & Outbound

More information

Summary Report. Report Q189

Summary Report. Report Q189 Summary Report Report Q189 Amendment of patent claims after grant (in court and administrative proceedings, including re examination proceedings requested by third parties) The intention with Q189 was

More information

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness Working Guidelines by Thierry CALAME, Reporter General Nicola DAGG and Sarah MATHESON, Deputy Reporters General John OSHA, Kazuhiko YOSHIDA and Sara ULFSDOTTER Assistants to the Reporter General Q217 The

More information

Threats & Opportunities in Proceedings before the EPO with a brief update on the Unitary Patent

Threats & Opportunities in Proceedings before the EPO with a brief update on the Unitary Patent Threats & Opportunities in Proceedings before the EPO with a brief update on the Unitary Patent MassMEDIC Jens Viktor Nørgaard & Peter Borg Gaarde September 13, 2013 Agenda Meet the speakers Threats &

More information

Patent Fees and Pricing: Structures and Policies

Patent Fees and Pricing: Structures and Policies Patent Fees and Pricing: Structures and Policies The Output of R&D activities: Harnessing the Power of Patent Data JRC-IPTS 4 th Workshop Nikolaus Thumm, EPO Chief Economist Sevilla 24 May, 2012 Background

More information

The Unitary Patent Package: Twelve Reasons for Concern

The Unitary Patent Package: Twelve Reasons for Concern The Unitary Patent Package: Twelve Reasons for Concern The proposed Unitary Patent Package currently under discussion consists of (see Annex 1) - a Regulation on the European patent with unitary effect

More information

Added matter under the EPC. Chris Gabriel Examiner Directorate 1222

Added matter under the EPC. Chris Gabriel Examiner Directorate 1222 Added matter under the EPC Chris Gabriel Examiner Directorate 1222 April 2018 Contents Added matter under the EPC Basic principles under the EPC First to file Article 123(2) EPC Interpretation Gold standard

More information

G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM

G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM THE ENLARGED BOARD OF APPEAL WILL BE WELCOME By Jean-Robert CALLON DE LAMARCK Partner European and French Patent Attorney The debate on software

More information

Deferred examination of European patent applications. 2. German delegation 3. Netherlands delegation

Deferred examination of European patent applications. 2. German delegation 3. Netherlands delegation CA/51/09 Orig.: en Munich, 06.03.2009 SUBJECT: SUBMITTED BY: ADDRESSEES: Deferred examination of European patent applications 1. Danish delegation 2. German delegation 3. Netherlands delegation Administrative

More information

Chapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3))

Chapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3)) Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part IV Chapter 2 Amendment Adding New Matter Chapter 2 Amendment Adding New Matter

More information

R 84a EPC does not apply to filing date itself as was no due date missed. So, effective date for and contacts subject matter is

R 84a EPC does not apply to filing date itself as was no due date missed. So, effective date for and contacts subject matter is Candidate s Answer DII 1. HVHF plugs + PP has: US2 - granted in US (related to US 1) EP1 - pending before EPO + + for all states LBP has: FR1 - France - still pending? EP2 - granted for DE, ES, FR, GB

More information

Evidence in EPO Proceedings. Dr. Joachim Renken Madrid, November 14, 2016

Evidence in EPO Proceedings. Dr. Joachim Renken Madrid, November 14, 2016 Evidence in EPO Proceedings Dr. Joachim Renken Madrid, November 14, 2016 General Principles Who carries the burden of proof during prosecution? Who bears the burden during opposition? Exceptions Who bears

More information

pct2ep.com Guide to claim amendment after EPO regional phase entry

pct2ep.com Guide to claim amendment after EPO regional phase entry pct2ep.com Guide to claim amendment after EPO regional phase entry Claim amendments in the EPO Guide to the issues to consider After a PCT application enters the EPO regional phase, and before any search

More information

Amendments in Europe and the United States

Amendments in Europe and the United States 13 Euro IP ch2-6.qxd 15/04/2009 11:16 Page 90 90 IP FIT FOR PURPOSE Amendments in Europe and the United States Attitudes differ if you try to broaden your claim after applications, reports Annalise Holme.

More information

PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION

PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION The idea of a Community Patent, a single patent that can be enforced throughout the European Union (EU), is hardly new. The original

More information

European Patent Opposition Proceedings

European Patent Opposition Proceedings European Patent Opposition Proceedings www.bardehle.com 2 Content 5 Initiating opposition proceedings 5 Grounds for revocation 6 Course of first instance proceedings 8 The appeal proceedings 10 Procedural

More information

Construction of second medical use claims. The Hon. Mr Justice Richard Arnold

Construction of second medical use claims. The Hon. Mr Justice Richard Arnold Construction of second medical use claims The Hon. Mr Justice Richard Arnold The problem Claim 1 of European Patent (UK) No. 0 934 061 reads: Use of [pregabalin] or a pharmaceutically acceptable salt thereof

More information

Lessons learnt 6 February 2015

Lessons learnt 6 February 2015 Patent infringement Lessons learnt from patent case law in Europe in 2013 and 2014 Véron & Associés Seminar Paris Maison de la Recherche Sabine Agé Paris Lyon Patent infringement Bolar exemption (1/2)

More information

Overview of Trial for Invalidation and Opposition Systems in Japan. March 2017 Trial and Appeal Department Japan Patent Office

Overview of Trial for Invalidation and Opposition Systems in Japan. March 2017 Trial and Appeal Department Japan Patent Office Overview of Trial for Invalidation and Opposition Systems in Japan March 2017 Trial and Appeal Department Japan Patent Office 1 Roles of Trial and Appeal Department of JPO Reviewing the examination ->

More information